PureTech Announces Participation in Two Upcoming Investor Conferences

On November 15, 2021 PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, reported that members of the management team will participate in fireside chats at the following upcoming investor conferences (Press release, PureTech Health, NOV 15, 2021, View Source [SID1234595612]). Webcasts of the presentations will be available at View Source

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Piper Sandler 33rd Annual Virtual Healthcare Conference

Presenters: George Farmer, Ph.D., Chief Financial Officer; Michael Chen, Ph.D., Head of Innovation

Date: Fireside chat available as of 10:00 AM EST on Monday, November 22, 2021

Evercore ISI 4th Annual HealthCONx Conference

Presenters: Daphne Zohar, Founder and CEO; Michael Chen, Ph.D., Head of Innovation

Date: Thursday, December 2, 2021

Time: 11:45 AM EST